E84.0
Conditions
Interventions
Group 1: Comparison of lung functions parameters and diaphragmatic mobility before and after mucus mobilisation with the device with the CR-number 30483.
1) sampling of expectorated mucus and determin
Sponsors
Ulm University Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: diagnosed cystic fibrosis
Exclusion criteria
Exclusion criteria: - acute infection - reduced general condition - massive hemoptysis within the last 4 weeks - pneumothorax within the last 6 weeks - uncontrolled asthmatic symptoms - unstable cardiovascular disease - unstable pulmonary situation with dyspnea - pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| lung function parameters (FEV1, MEF25, MEF50, MEF75), measured by spirometry | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Diaphragmatic mobility before and after the intervention; sonographic measurement of the diaphragmatic excursion and speed of the diaphragmatic movement of in- and expiration 2. Viscosity and DNA-concentration of the expectorated mucus before and after the intervention; measurement via FRAP (fluorescence recovery after Photobleaching) and dye based determination of DNA-concentration | — |
Countries
Germany
Contacts
Public ContactDorit Fabricius
Ulm University Medical Center
Outcome results
None listed